Literature DB >> 11777334

Cancer cell motility--on the road from c-erbB-2 receptor steered signaling to actin reorganization.

Julia C Feldner1, Burkhard H Brandt.   

Abstract

Cell migration depends mainly on actin polymerization and intracellular organization, which are influenced by a vast variety of actin binding proteins (ABPs). Regulation of ABP activity is mediated by second messengers such as phosphoinositides and calcium. Signaling via these second messengers is initiated and regulated by membrane receptors, e.g., receptor tyrosine kinases (RTKs), and by adhesion molecule interactions (e.g., integrins and selectins) and focal adhesion kinases. A major role in steering second-messenger signaling and thus in actin cytoskeleton reorganization and motility of cancer cells is played by the RTK c-erbB-2. This occurs through a number of signaling pathways which involve mainly enzymes, e.g., phospholipase Cgamma1 and GTPases, which modify signaling molecules. Furthermore large multiprotein complexes including actin-related protein 2/3, Wiskott-Aldrich syndrome protein, profilin, and capping protein among others play an important role in regulating actin reorganization. The complex picture of the mode of actin reorganization, which is involved in tumor cell migration, is slowly emerging from the mists of cellular signaling pathways, but this is still by no means a clear view. (c)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11777334     DOI: 10.1006/excr.2001.5385

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  31 in total

1.  Association with membrane protrusions makes ErbB2 an internalization-resistant receptor.

Authors:  Anette M Hommelgaard; Mads Lerdrup; Bo van Deurs
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

Review 2.  The ErbB2 signaling network as a target for breast cancer therapy.

Authors:  Ali Badache; Anthony Gonçalves
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

3.  MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1.

Authors:  Jennifer J Rahn; Jeffrey W Chow; Garnet J Horne; Brian K Mah; Joanne T Emerman; Pat Hoffman; Judith C Hugh
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk.

Authors:  Wei Zou; Jennifer L Reeve; Yuli Liu; Steven L Teitelbaum; F Patrick Ross
Journal:  Mol Cell       Date:  2008-08-08       Impact factor: 17.970

Review 5.  Structure and functions of profilins.

Authors:  Kannan Krishnan; Pierre D J Moens
Journal:  Biophys Rev       Date:  2009-06-04

Review 6.  Molecular imaging of integrin αvβ6 expression in living subjects.

Authors:  Hao Liu; Yue Wu; Fan Wang; Zhaofei Liu
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-06-07

Review 7.  MUC1-mediated motility in breast cancer: a review highlighting the role of the MUC1/ICAM-1/Src signaling triad.

Authors:  Lacey Haddon; Judith Hugh
Journal:  Clin Exp Metastasis       Date:  2015-03-11       Impact factor: 5.150

8.  The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein.

Authors:  Hongbing Li; Juan Sánchez-Torres; Alan Del Carpio; Valentina Salas; Antonio Villalobo
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

Review 9.  Defining the role of integrin alphavbeta6 in cancer.

Authors:  A Bandyopadhyay; S Raghavan
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

10.  BCL2 inhibits cell adhesion, spreading, and motility by enhancing actin polymerization.

Authors:  Hengning Ke; Vandy I Parron; Jeff Reece; Jennifer Y Zhang; Steven K Akiyama; John E French
Journal:  Cell Res       Date:  2010-02-09       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.